ANEW Medical (WENA) Competitors

$0.73

-0.07 (-8.75%)

(As of 09/6/2024 ET)

Stock Analysis Chart Competitors Earnings Financials SEC Filings Short Interest Trends

WENA vs. ATNM, SCYX, DRRX, GRTS, BLRX, BRNS, PRPH, RPHM, RLYB, and ANEB

Should you be buying ANEW Medical stock or one of its competitors? The main competitors of ANEW Medical include Actinium Pharmaceuticals (ATNM), SCYNEXIS (SCYX), DURECT (DRRX), Gritstone bio (GRTS), BioLineRx (BLRX), Barinthus Biotherapeutics (BRNS), ProPhase Labs (PRPH), Reneo Pharmaceuticals (RPHM), Rallybio (RLYB), and Anebulo Pharmaceuticals (ANEB). These companies are all part of the "pharmaceutical products" industry.

ANEW Medical vs.

Actinium Pharmaceuticals (NYSE:ATNM) and ANEW Medical (NASDAQ:WENA) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, risk, profitability, earnings, dividends, analyst recommendations, community ranking, valuation and institutional ownership.

: Actinium Pharmaceuticals received 3 more outperform votes than ANEW Medical when rated by MarketBeat users.
Company Underperform Outperform
Actinium Pharmaceuticals Outperform Votes
3
37.50%
Underperform Votes
5
62.50%
ANEW Medical N/A N/A
: ANEW Medical has lower revenue, but higher earnings than Actinium Pharmaceuticals.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Actinium Pharmaceuticals $81K 654.49 -$48.82M -$1.71 -1.04
ANEW Medical N/A N/A N/A N/A N/A
: Actinium Pharmaceuticals currently has a consensus price target of $11.40, suggesting a potential upside of 540.45%. Given Actinium Pharmaceuticals' higher possible upside, analysts plainly believe Actinium Pharmaceuticals is more favorable than ANEW Medical.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Actinium Pharmaceuticals
0 Sell rating(s)
1 Hold rating(s)

4 Buy rating(s)

0 Strong Buy rating(s)
2.80
ANEW Medical
0 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
N/A
: In the previous week, Actinium Pharmaceuticals had 1 more articles in the media than ANEW Medical. MarketBeat recorded 2 mentions for Actinium Pharmaceuticals and 1 mentions for ANEW Medical. ANEW Medical's average media sentiment score of 0.33 beat Actinium Pharmaceuticals' score of 0.00 indicating that ANEW Medical is being referred to more favorably in the news media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Actinium Pharmaceuticals
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
ANEW Medical
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
: ANEW Medical's return on equity of 0.00% beat Actinium Pharmaceuticals' return on equity.
Company Net Margins Return on Equity Return on Assets
Actinium Pharmaceuticals N/A -101.69% -48.91%
ANEW Medical N/A N/A N/A
: 27.5% of Actinium Pharmaceuticals shares are owned by institutional investors. Comparatively, 20.1% of ANEW Medical shares are owned by institutional investors. 4.0% of Actinium Pharmaceuticals shares are owned by insiders. Comparatively, 2.0% of ANEW Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Company	Underperform	Outperform
Actinium Pharmaceuticals	Outperform Votes 3 37.50%	Underperform Votes 5 62.50%
ANEW Medical	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Actinium Pharmaceuticals	$81K	654.49	-$48.82M	-$1.71	-1.04
ANEW Medical	N/A	N/A	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Actinium Pharmaceuticals	0 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.80
ANEW Medical	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Actinium Pharmaceuticals	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
ANEW Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Company	Net Margins	Return on Equity	Return on Assets
Actinium Pharmaceuticals	N/A	-101.69%	-48.91%
ANEW Medical	N/A	N/A	N/A

Summary

Actinium Pharmaceuticals beats ANEW Medical on 7 of the 10 factors compared between the two stocks.

Ad Porter & Company

The death of Nvidia?

Today, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S. housing… it's in artificial intelligence. And unless you know what’s really going on in this sector, you could be wiped out. You see, while there is no doubt that the recent advancements in artificial intelligence are game-changing and will drive colossal innovation in every sector of the economy... There's also no escaping that The Big AI Die-Up is coming.

So go here now to read my new report The Big AI Die-Up… while you still can.

Get ANEW Medical News Delivered to You Automatically

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding WENA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

WENA vs. The Competition

Export to Excel

Metric	ANEW Medical	Holding Offices Industry	Medical Sector	NASDAQ Exchange
Market Cap	$3.77M	$396.28M	$5.67B	$7.87B
Dividend Yield	N/A	7.54%	2.73%	4.02%
P/E Ratio	N/A	5.93	115.16	17.66
Price / Sales	N/A	10.45	1,747.68	68.05
Price / Cash	N/A	69.09	38.68	32.60
Price / Book	N/A	67.76	4.94	4.42
Net Income	N/A	$27.87M	$114.59M	$224.46M
7 Day Performance	-21.54%	-1.78%	-1.52%	-3.60%
1 Month Performance	-33.00%	1.81%	8.44%	5.28%
1 Year Performance	N/A	-4.63%	12.44%	4.44%

ANEW Medical Competitors List

Export to Excel

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ATNM Actinium Pharmaceuticals	0.524 of 5 stars 0.52 / 5 stars	$1.75 +1.5%	$11.43 +555.2%	N/A	$51.97M	$81,000.00	-1.02	30
SCYX SCYNEXIS	0 of 5 stars 0.00 / 5 stars	$1.35 +0.4%	N/A	-63.2%	$50.92M	$140.14M	0.66	60	Positive News
DRRX DURECT	2.3544 of 5 stars 2.35 / 5 stars	$1.62 +1.9%	$21.00 +1,196.3%	-45.7%	$50.28M	$8.41M	-1.71	80	Positive News
GRTS Gritstone bio	2.246 of 5 stars 2.25 / 5 stars	$0.46 -1.2%	$4.75 +932.4%	-72.7%	$49.95M	$496,000.00	-0.37	190	Positive News
BLRX BioLineRx	2.2391 of 5 stars 2.24 / 5 stars	$0.62 -1.6%	$21.00 +3,314.6%	-74.8%	$49.16M	$17.05M	-0.81	40
BRNS Barinthus Biotherapeutics	2.8592 of 5 stars 2.86 / 5 stars	$1.23 -3.9%	$5.83 +374.3%	N/A	$48.49M	$800,000.00	-0.67	107	Positive News Gap Up High Trading Volume
PRPH ProPhase Labs	2.2485 of 5 stars 2.25 / 5 stars	$2.53 -2.3%	$11.00 +334.8%	-36.0%	$48.27M	$44.38M	-2.34	130
RPHM Reneo Pharmaceuticals	1.345 of 5 stars 1.35 / 5 stars	$1.43 flat	$11.01 +670.1%	-79.4%	$47.81M	N/A	-0.66	30	Gap Up
RLYB Rallybio	2.5722 of 5 stars 2.57 / 5 stars	$1.15 +3.6%	$10.00 +769.6%	-79.7%	$47.71M	N/A	-0.61	40	Analyst Forecast
ANEB Anebulo Pharmaceuticals	2.6893 of 5 stars 2.69 / 5 stars	$1.80 -4.3%	$6.67 +270.4%	-34.5%	$46.68M	N/A	-4.86	4	Gap Down